IBDEI0M9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10159,0)
 ;;=L20.82^^68^664^150
 ;;^UTILITY(U,$J,358.3,10159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10159,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,10159,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,10159,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,10160,0)
 ;;=L20.84^^68^664^162
 ;;^UTILITY(U,$J,358.3,10160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10160,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,10160,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,10160,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,10161,0)
 ;;=L20.89^^68^664^85
 ;;^UTILITY(U,$J,358.3,10161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10161,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,10161,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,10161,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,10162,0)
 ;;=L20.9^^68^664^86
 ;;^UTILITY(U,$J,358.3,10162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10162,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10162,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,10162,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,10163,0)
 ;;=L21.8^^68^664^262
 ;;^UTILITY(U,$J,358.3,10163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10163,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,10163,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,10163,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,10164,0)
 ;;=L21.9^^68^664^263
 ;;^UTILITY(U,$J,358.3,10164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10164,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10164,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,10164,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,10165,0)
 ;;=L23.7^^68^664^30
 ;;^UTILITY(U,$J,358.3,10165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10165,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,10165,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,10165,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,10166,0)
 ;;=L23.9^^68^664^31
 ;;^UTILITY(U,$J,358.3,10166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10166,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10166,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,10166,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,10167,0)
 ;;=L24.9^^68^664^163
 ;;^UTILITY(U,$J,358.3,10167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10167,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10167,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,10167,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,10168,0)
 ;;=L25.9^^68^664^115
 ;;^UTILITY(U,$J,358.3,10168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10168,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,10168,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,10168,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,10169,0)
 ;;=L26.^^68^664^148
 ;;^UTILITY(U,$J,358.3,10169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10169,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,10169,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,10169,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,10170,0)
 ;;=L27.0^^68^664^265
 ;;^UTILITY(U,$J,358.3,10170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10170,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,10170,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,10170,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,10171,0)
 ;;=L27.1^^68^664^266
 ;;^UTILITY(U,$J,358.3,10171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10171,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,10171,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,10171,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,10172,0)
 ;;=L29.0^^68^664^250
 ;;^UTILITY(U,$J,358.3,10172,1,0)
 ;;=^358.31IA^4^2
